Showing results (81-90 of 138) with videos related to
Sort By:
Pageof 14
European Heart Journal|June 2, 2007
Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trialsNeil J Weissman, Stephen G Ellis, Eberhard Grube, et al.Circulation|June 10, 2010
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trialMarie-Claude Morice, Patrick W Serruys, A Pieter Kappetein, et al.Circulation. Cardiovascular Interventions|July 22, 2010
Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI)Giulio Guagliumi, Vasile Sirbu, Giuseppe Musumeci, et al.Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|July 7, 2009
Expanded use of the TAXUS Express Stent: two-year safety insights from the 7,500 patient ARRIVE Registry programmeJohn M Lasala, David A Cox, Stephen J Lewis, et al.JACC. Cardiovascular Interventions|December 21, 2013
Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery)Chrysafios Girasis, Vasim Farooq, Roberto Diletti, et al.Journal of the American College of Cardiology|February 21, 2012
Primary endpoint results of the EVOLVE trial: a randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stentIan T Meredith, Stefan Verheye, Christophe L Dubois, et al.Journal of Cardiology|January 28, 2014
Japanese and non-Japanese patient outcomes in the PLATINUM randomized trial comparing the PROMUS Element and XIENCE V everolimus-eluting stentsShigeru Saito, Nobuhisa Hagiwara, Atsushi Seki, et al.The New England Journal of Medicine|March 18, 2011
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgeryDavid J Cohen, Ben Van Hout, Patrick W Serruys, et al.JACC. Cardiovascular Interventions|February 5, 2010
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent TrialsHiroshi Doi, Akiko Maehara, Gary S Mintz, et al.Coronary Artery Disease|June 10, 2014
Stenting for ST-segment elevation myocardial infarction is associated with less neointimal hyperplasia in the pooled IVUS analysis from HORIZONS-AMI and the TAXUS IV and V and ATLAS workhorse, long lesion, and direct stent studiesNobuaki Kobayashi, Akiko Maehara, Dominic Allocco, et al.Pageof 14